Histopathology in the placentae of women with antiphospholipid antibodies: A systematic review of the literature

D'Cruz, 2006, Antiphospholipid (Hughes) syndrome: an overview, 9 Pattison, 1993, Antiphospholipid antibodies in pregnancy: prevalence and clinical associations, Br J Obstet Gynaecol, 100, 909, 10.1111/j.1471-0528.1993.tb15105.x Birdsall, 1992, Antiphospholipid antibodies in pregnancy, Aust N Z J Obstet Gynaecol, 32, 328, 10.1111/j.1479-828X.1992.tb02844.x Lockwood, 1989, The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population, Am J Obstet Gynecol, 161, 369, 10.1016/0002-9378(89)90522-X Petri, 2006, Epidemiology of antiphospholipid antibody syndrome, 22 Rai, 1995, High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies, Hum Reprod, 10, 3301, 10.1093/oxfordjournals.humrep.a135907 Yasuda, 1995, Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy, Obstet Gynecol, 86, 555, 10.1016/S0029-7844(95)80015-8 Allen, 1996, Antiphospholipid antibodies in patients with preeclampsia, Am J Reprod Immunol, 36, 81, 10.1111/j.1600-0897.1996.tb00143.x Branch, 1989, The association of antiphospholipid antibodies with severe preeclampsia, Obstet Gynecol, 73, 541 Katano, 1996, beta 2-Glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women, Hum Reprod, 11, 509, 10.1093/HUMREP/11.3.509 Harris, 1986, Thrombosis, recurrent fetal loss, and thrombocytopenia: predictive value of the anticardiolipin antibody test, Arch Intern Med, 146, 2153, 10.1001/archinte.1986.00360230069012 Harris, 1983, Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus, Lancet, 322, 1211, 10.1016/S0140-6736(83)91267-9 Reynaud, 2014, Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis, Autoimmun Rev, 13, 595, 10.1016/j.autrev.2013.11.004 Wahl, 1998, Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis, Lupus, 7, 15, 10.1191/096120398678919688 Miyakis, 2006, International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), J Thromb Haemost, 4, 295, 10.1111/j.1538-7836.2006.01753.x Benirschke, 2000 Huppertz, 1998, Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta, Histochem Cell Biol, 110, 495, 10.1007/s004180050311 Mayhew, 1999, Proliferation, differentiation and apoptosis in villous trophoblast at 13–41 weeks of gestation (including observations on annulate lamellae and nuclear pore complexes), Placenta, 20, 407, 10.1053/plac.1999.0399 Benirschke, 2012 Askelund, 2011, Trophoblast deportation part I: review of the evidence demonstrating trophoblast shedding and deportation during human pregnancy, Placenta, 32, 716, 10.1016/j.placenta.2011.07.081 Pantham, 2011, Trophoblast deportation part II: a review of the maternal consequences of trophoblast deportation, Placenta, 32, 724, 10.1016/j.placenta.2011.06.019 Huppertz, 2006, Apoptosis and its role in the trophoblast, Am J Obstet Gynecol, 195, 29, 10.1016/j.ajog.2005.07.039 Fox, 1997 Tong, 2014, Antiphospholipid antibodies and the placenta: a systematic review of their in vitro effects and modulation by treatment, Hum Reprod Update, 21, 97, 10.1093/humupd/dmu049 Chamley, 1998, Action of anticardiolipin and antibodies to [beta]2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death, Lancet, 352, 1037, 10.1016/S0140-6736(05)60080-3 Adler, 1995, Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR Biol Reprod, 53, 905, 10.1095/biolreprod53.4.905 Di Simone, 1999, Low-molecular weight heparin restores in-vitro trophoblast invasiveness and differentiation in presence of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome, Hum Reprod, 14, 489, 10.1093/humrep/14.2.489 Blank, 2007, The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model, Int Immunol, 19, 857, 10.1093/intimm/dxm052 Han, 2011, Aspirin and heparin effect on basal and antiphospholipid antibody modulation of trophoblast function, Obstet Gynecol, 118, 1021, 10.1097/AOG.0b013e31823234ad Jovanovic, 2010, Effects of anti-phospholipid antibodies on a human trophoblast cell line (HTR-8/SVneo), Acta Histochem, 112, 34, 10.1016/j.acthis.2008.07.001 Katsuragawa, 1997, Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion, Biol Reprod, 56, 50, 10.1095/biolreprod56.1.50 Mulla, 2010, Antiphospholipid antibodies limit trophoblast migration by reducing IL-6 production and STAT3 activity, Am J Reprod Immunol, 63, 339, 10.1111/j.1600-0897.2009.00805.x Rote, 1998, The role of placental trophoblast in the pathophysiology of the antiphospholipid antibody syndrome, Am J Reprod Immunol, 39, 125, 10.1111/j.1600-0897.1998.tb00344.x Bose, 2004, Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro, Am J Obstet Gynecol, 191, 2125, 10.1016/j.ajog.2004.05.014 Ornoy, 2003, The effects of antiphospholipid antibodies obtained from women with SLE/APS and associated pregnancy loss on rat embryos and placental explants in culture, Lupus, 12, 573, 10.1191/0961203303lu405oa Schwartz, 2007, Reduced placental growth and hCG secretion in vitro induced by antiphospholipid antibodies but not by anti-Ro or anti-La: studies on sera from women with SLE/PAPS, Lupus, 16, 110, 10.1177/0961203306075741 Chen, 2009, Anti-phospholipid antibodies increase non-apoptotic trophoblast shedding: a contribution to the pathogenesis of pre-eclampsia in affected women?, Placenta, 30, 767, 10.1016/j.placenta.2009.06.008 Campos, 2006, Determination of non-bilayer phospholipid arrangements and their antibodies in placentae and sera of patients with hypertensive disorders of pregnancy, Placenta, 27, 215, 10.1016/j.placenta.2005.01.010 Katsuragawa, 1995, Monoclonal antiphosphatidylserine antibody reactivity against human first-trimester placental trophoblasts, Am J Obstet Gynecol, 172, 1592, 10.1016/0002-9378(95)90502-2 Lyden, 1992, Monoclonal antiphospholipid antibody reactivity against human placental trophoblast, J Reprod Immunol, 22, 1, 10.1016/0165-0378(92)90002-L Zwaal, 2005, Surface exposure of phosphatidylserine in pathological cells, Cell Mol Life Sci, 62, 971, 10.1007/s00018-005-4527-3 Tait, 1989, Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family, J Biol Chem, 264, 7944, 10.1016/S0021-9258(18)83133-7 Rand, 2003, Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay, Am J Pathol, 163, 1193, 10.1016/S0002-9440(10)63479-7 Rand, 1997, Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi, Am J Obstet Gynecol, 177, 918, 10.1016/S0002-9378(97)70294-1 Rand, 1994, Reduction of annexin-V (placental anticoagulant protein-I) on placental v ll of women with antiphospholipid antibodies and recurrent-spontaneous abortion, Am J Obstet Gynecol, 171, 1566, 10.1016/0002-9378(94)90403-0 Rand, 1997, Pregnancy loss in the antiphospholipid-antibody syndrome—a possible thrombogenic mechanism, N Engl J Med, 337, 154, 10.1056/NEJM199707173370303 Rand, 2010, Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug, Blood, 115, 2292, 10.1182/blood-2009-04-213520 Vogt, 1997, Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation, Am J Obstet Gynecol, 177, 964, 10.1016/S0002-9378(97)70302-8 Wu, 2011, Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression, Am J Obstet Gynecol, 205 Holers, 2002, Complement C3 activation is required for antiphospholipid antibody-induced fetal loss, J Exp Med, 195, 211, 10.1084/jem.200116116 Girardi, 2003, Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome, J Clin Invest, 112, 1644, 10.1172/JCI200318817 Redecha, 2007, Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury, Blood, 110, 2423, 10.1182/blood-2007-01-070631 Mulla, 2009, Antiphospholipid antibodies induce a pro-inflammatory response in first trimester trophoblast via the TLR4/MyD88 pathway, Am J Reprod Immunol, 62, 96, 10.1111/j.1600-0897.2009.00717.x De Wolf, 1982, Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant, Am J Obstet Gynecol, 142, 829, 10.1016/S0002-9378(16)32527-3 Branch, 1985, Obstetric complications associated with the lupus anticoagulant, N Engl J Med, 313, 1322, 10.1056/NEJM198511213132104 Gardlund, 1984, The lupus inhibitor in thromboembolic disease and intrauterine death in the absence of systemic lupus, Acta Med Scand, 215, 293, 10.1111/j.0954-6820.1984.tb05010.x Salafia, 1997, Placental pathology and antiphospholipid antibodies: a descriptive study, Am J Perinatol, 14, 435, 10.1055/s-2007-994176 Alijotas-Reig, 2008, Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?, Am J Reprod Immunol, 60, 229, 10.1111/j.1600-0897.2008.00618.x Rosove, 1990, Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies, Obstet Gynecol, 75, 630 Katano, 1995, Specific antiphospholipid antibodies (aPL) eluted from placentae of pregnant women with aPL-positive sera, Lupus, 4, 304, 10.1177/096120339500400412 Silver, 1994, Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death, Obstet Gynecol, 83, 150 Kowal-Vern, 1996, Placental pathologic conditions in anticardiolipin antibody positive women whose infants had congenital heart defects, J Perinatol, 16, 268 Sebire, 2002, Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure, Hum Reprod, 17, 1067, 10.1093/humrep/17.4.1067 Van Horn, 2004, Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid-like syndromes, Placenta, 25, 642, 10.1016/j.placenta.2003.12.006 Gonen, 2005, Absence of association of inherited thrombophilia with unexplained third-trimester intrauterine fetal death, Am J Obstet Gynecol, 192, 742, 10.1016/j.ajog.2004.12.050 Magid, 1998, Placental pathology in systemic lupus erythematosus: a prospective study, Am J Obstet Gynecol, 179, 226, 10.1016/S0002-9378(98)70277-7 Ogishima, 2000, Placental pathology in systemic lupus erythematosus with antiphospholipid antibodies, Pathol Int, 50, 224, 10.1046/j.1440-1827.2000.01026.x Out, 1991, Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies, Eur J Obstet Gynecol Reprod Biol, 41, 179, 10.1016/0028-2243(91)90021-C Ackerman, 1999, Immunological studies of the placenta in maternal connective tissue disease, Pediatr Dev Pathol, 2, 19, 10.1007/s100249900085 Hanly, 1988, Lupus pregnancy. a prospective study of placental changes, Arthritis Rheum, 31, 358, 10.1002/art.1780310307 La Rosa, 1994, Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome, J Rheumatol, 21, 1684 Lockshin, 1985, Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus, N Engl J Med, 313, 152, 10.1056/NEJM198507183130304 Gris, 1999, Case–control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent—the Nîmes Obstetricians and Haematologists Study 5 (NOHA5), Thromb Haemost, 81, 891, 10.1055/s-0037-1614594 Ilaria, 2007, Complement activation in anti-phospholipid syndrome: a clue for an inflammatory process?, J Autoimmun, 28, 160, 10.1016/j.jaut.2007.02.013 Stone, 2006, The placental bed in pregnancies complicated by primary antiphospholipid syndrome, Placenta, 27, 457, 10.1016/j.placenta.2005.04.006 Sebire, 2003, Placental pathology, antiphospholipid antibodies, and pregnancy outcome in recurrent miscarriage patients, Obstet Gynecol, 101, 258, 10.1016/S0029-7844(02)02385-2 Lakasing, 2000, Normal expression of cell adhesion molecules in placentae from women with systemic lupus erythematosus and the antiphospholipid syndrome, Placenta, 21, 142, 10.1053/plac.1999.0478 Hasegawa, 1990, Cytotoxic antibody against trophoblast and lymphocytes present in pregnancy with intra-uterine fetal growth retardation and its relation to anti-phospholipid antibody, J Reprod Immunol, 17, 127, 10.1016/0165-0378(90)90031-Z Ghosh, 2006, Anti-phospholipid antibodies as a cause of recurrent pregnancy loss: a study in Calcutta, India, J Obstet Gynaecol, 26, 407, 10.1080/01443610600719974 Cohen, 2012, Pros and cons for C4d as a biomarker, Kidney Int, 81, 628, 10.1038/ki.2011.497 Cohen, 2011, Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss, J Pathol, 225, 502, 10.1002/path.2893 Shamonki, 2007, Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies, Am J Obstet Gynecol, 196, e161 Morgan, 1995, Physiology and pathophysiology of complement: progress and trends, Crit Rev Clin Lab Sci, 32, 265, 10.3109/10408369509084686 Donohoe, 2000, Ontogeny of beta 2 glycoprotein I and annexin V in villous placenta of normal and antiphospholipid syndrome pregnancies, Thromb Haemost, 84, 32, 10.1055/s-0037-1613963 Lakasing, 1999, Normal expression of tissue factor, thrombomodulin, and annexin V in placentas from women with antiphospholipid syndrome, Am J Obstet Gynecol, 181, 180, 10.1016/S0002-9378(99)70457-6 de Castellarnau, 1988, Serial measurements of a plasma prostacyclin inhibitor in a patient with recurrent abortions and lupus anticoagulant; a case report, Eur J Obstet Gynecol Reprod Biol, 29, 173, 10.1016/0028-2243(88)90145-1 Piona, 1995, Placental thrombosis and fetal loss after passive transfer of mouse lupus monoclonal or human polyclonal anti-cardiolipin antibodies in pregnant naive BALB/c mice, Scand J Immunol, 41, 427, 10.1111/j.1365-3083.1995.tb03588.x Poindron, 2011, Evidence for heterogeneity of the obstetric antiphospholipid syndrome: thrombosis can be critical for antiphospholipid-induced pregnancy loss, J Thromb Haemost, 9, 1937, 10.1111/j.1538-7836.2011.04475.x Jaffe, 1997, Maternal circulation in the first-trimester human placenta—myth or reality?, Am J Obstet Gynecol, 176, 695, 10.1016/S0002-9378(97)70572-6 Nayar, 1996, Placental changes in a first trimester missed abortion in maternal systemic lupus erythematosus with antiphospholipid syndrome: a case report and review of the literature, Hum Pathol, 27, 201, 10.1016/S0046-8177(96)90377-9 Brosens, 1972, The role of spiral arteries in the pathogenesis of pre-eclampsia, Obstet Gynecol Annu, 1, 177 Gerretsen, 1981, Morphological changes of the spiral arteries in the placentae bed in relation to pre-eclampsia and fetal growth retardation, BJOG Int J Obstet Gynaecol, 88, 876, 10.1111/j.1471-0528.1981.tb02222.x Hustin, 1983, Maternal vascular lesions in pre-eclampsia and intrauterine growth retardation: light microscopy and immunofluorescence, Placenta, 4, 489 Duckitt, 2005, Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies, BMJ, 330, 565, 10.1136/bmj.38380.674340.E0 Lanir, 2003, Haemostatic mechanisms in human placenta, Best Pract Res Clin Haematol, 16, 183, 10.1016/S1521-6926(02)00098-1 Abrahams, 2004, Divergent trophoblast responses to bacterial products mediated by TLRs, J Immunol, 173, 4286, 10.4049/jimmunol.173.7.4286 Kumazaki, 2004, Immunohistochemical distribution of Toll-like receptor 4 in term and preterm human placentas from normal and complicated pregnancy including chorioamnionitis, Hum Pathol, 35, 47, 10.1016/j.humpath.2003.08.027 Holmes, 1992, Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55), Eur J Immunol, 22, 1579, 10.1002/eji.1830220635 Wirstlein, 2012, Complement inhibitory proteins expression in placentas of thrombophilic women, Folia Histochem Cytobiol, 50, 460, 10.5603/FHC.2012.0064 Liszewski, 1996, Membrane cofactor protein (MCP; CD46). Isoforms differ in protection against the classical pathway of complement, J Immunol, 156, 4415, 10.4049/jimmunol.156.11.4415 Kim, 1995, Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein, J Exp Med, 181, 151, 10.1084/jem.181.1.151 Devisme, 2013, A case–control study of placental lesions associated with pre-eclampsia, Int J Gynecol Obstet, 120, 165, 10.1016/j.ijgo.2012.08.023 Heazell, 2007, Formation of syncytial knots is increased by hyperoxia, hypoxia and reactive oxygen species, Placenta, 28, S33, 10.1016/j.placenta.2006.10.007 Sankar, 2012, Vasculosyncytial membrane in relation to syncytial knots complicates the placenta in preeclampsia: a histomorphometrical study, Anat Cell Biol, 45, 86, 10.5115/acb.2012.45.2.86 Tomas, 2011, Trophoblast apoptosis in placentas from pregnancies complicated by preeclampsia, Gynecol Obstet Invest, 71, 250, 10.1159/000320289 Chua, 1991, Trophoblast deportation in pre-eclamptic pregnancy, Br J Obstet Gynaecol, 98, 973, 10.1111/j.1471-0528.1991.tb15334.x Jaameri, 1965, Occurrence of trophoblasts in the blood of toxaemic patients, Gynaecologia, 160, 315 Johansen, 1999, Trophoblast deportation in human pregnancy—its relevance for preeclampsia, Placenta, 20, 531, 10.1053/plac.1999.0422 Huppertz, 2008, Placental origins of preeclampsia: challenging the current hypothesis, Hypertension, 51, 970, 10.1161/HYPERTENSIONAHA.107.107607 Cohen, 2000, Anti-cardiolipin antibodies in fetal blood and amniotic fluid derived from patients with the anti-phospholipid syndrome, Hum Reprod, 15, 1170, 10.1093/humrep/15.5.1170 Mekinian, 2013, European registry of babies born to mothers with antiphospholipid syndrome, Ann Rheum Dis, 72, 217, 10.1136/annrheumdis-2011-201167 Motta, 2006, Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study, Am J Perinatol, 23, 247, 10.1055/s-2006-939533 Guvendag Guven, 2008, Placental Fas/Fas ligand expression in early pregnancy losses, Am J Reprod Immunol, 60, 1, 10.1111/j.1600-0897.2008.00583.x Albrecht, 2007, Placental ABCA1 expression is reduced in primary antiphospholipid syndrome compared to pre-eclampsia and controls, Placenta, 28, 701, 10.1016/j.placenta.2006.10.001 Locatelli, 2002, Pathology findings in preterm placentas of women with autoantibodies: a case–control study, J Matern Fetal Neonatal Med, 11, 339 Bose, 2006, Aberrations of early trophoblast differentiation predispose to pregnancy failure: lessons from the anti-phospholipid syndrome, Placenta, 27, 869, 10.1016/j.placenta.2005.09.007